Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001692444-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 26, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
82,782
Total Value
$2,386,605.06
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 24, 2026 | Exercise/Conversion | 27,594 | $8.44 | $232,893.36 | 27,594 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 24, 2026 | Sale | 27,594 | $78.05 | $2,153,711.70 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 24, 2026 | Exercise/Conversion | 27,594 | $0.00 | $0.00 | 1,198 | Direct | โ | View Details |